Prevalent vs Incident Screen: Why Does It Matter?

Area of Science:

• Oncology
• Radiology
• Public Health

Background:

• Breast cancer screening aims to detect cancer early for improved outcomes.
• Screening rounds are categorized as prevalent (first-time) or incident (subsequent).
• Differences in performance metrics between these screening types are not always fully appreciated.

Purpose of the Study:

• To highlight the key differences in cancer detection rates between prevalent and incident breast cancer screening rounds.
• To emphasize the importance of considering these differences when assessing screening technology effectiveness.
• To inform the interpretation of medical audit data for breast cancer screening programs.

Main Methods:

• Comparative analysis of screening round types (prevalent vs. incident).
• Review of cancer detection rates based on screening history.
• Consideration of the temporal aspect of cancer development and detection.

Main Results:

• Prevalent screening rounds identify a higher number of pre-existing cancers compared to incident rounds.
• Incident screening rounds detect cancers that have emerged since the previous examination.
• The cancer detection rate is inherently higher in the initial (prevalent) screening examination.

Conclusions:

• The distinction between prevalent and incident screening is critical for accurate performance evaluation.
• Higher cancer detection rates in prevalent screening should be factored into the assessment of new screening technologies.
• Understanding these differences is essential for robust medical audit and effectiveness studies in breast cancer screening.